Birdwatch Note
2022-07-31 17:14:12 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Although some initial studies early in the pandemic indicated Ivermectin may be useful, the conclusion is that Ivermectin is not effective as an antiviral treatment. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Written by DD716E5B0E50F0E1F626CD180E126B89
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1553731376641441792
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1553791147100848128
- noteId - 1553791147100848128
- participantId - DD716E5B0E50F0E1F626CD180E126B89
- noteAuthorParticipantId -
- createdAtMillis - 1659287652166
- tweetId - 1553731376641441792
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable - BELIEVABLE_BY_MANY
- harmful - CONSIDERABLE_HARM
- validationDifficulty - EASY
- misleadingOther - 0
- misleadingFactualError - 0
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 1
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 1
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Although some initial studies early in the pandemic indicated Ivermectin may be useful, the conclusion is that Ivermectin is not effective as an antiviral treatment. https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19 https://www.covid19treatmentguidelines.nih.gov/therapies/antiviral-therapy/ivermectin/
Note Status History
| createdAt | timestampMillisOfFirstNonNMRStatus | firstNonNMRStatus | timestampMillisOfCurrentStatus | currentStatus | timestampMillisOfLatestNonNMRStatus | mostRecentNonNMRStatus | participantId |
| 2022-07-31 17:14:12 UTC (1659287652166) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
AD8DC42A0C7729F56C4F30E56E6262C5285C3CADAB680599CAF1924DEA605484 | ||
| 2022-07-31 17:14:12 UTC (1659287652166) |
1969-12-31 23:59:59 UTC (-1) |
1969-12-31 23:59:59 UTC (-1) |
NEEDS_MORE_RATINGS | 1969-12-31 23:59:59 UTC (-1) |
DD716E5B0E50F0E1F626CD180E126B89 |
Note Ratings
| rated at | rated by | |
| 2022-08-01 20:35:11 -0500 | 0378F20DFECC73D3AD98390D25AA66E2BCCAAB4A22DEE65AB440D4CB6446B2E7 | Rating Details |
| 2022-08-01 16:46:37 -0500 | 0B7EA8CA53AF4D974F22F001262C253AFC72BBF48AC077B12807BC10673296E2 | Rating Details |
| 2022-07-31 20:06:09 -0500 | 1B16E817D4B4C49CC9BE11FE50696836 | Rating Details |
| 2022-08-01 08:05:25 -0500 | 1DFC782C541B1212198EDEB893CA0F73F701E6D66EAECFD92FBA402B91705BCB | Rating Details |
| 2022-08-01 15:37:24 -0500 | 22AE3115F75FCFB63BDA723149803A7CC3CFFE2FF870153DFA72FF8965A205FF | Rating Details |
| 2022-08-01 08:00:06 -0500 | 2399EC1A993F6983F4D894444E381D9EB8E8952E78890A0DE987BE72313826B2 | Rating Details |
| 2022-08-01 10:17:12 -0500 | 2AD5E24905E0F41A05EA42D64F4C2F1F46685ABD0685D956F4F070584996F3EF | Rating Details |
| 2022-08-01 01:06:21 -0500 | 2C0C323337CADA4A449209AD8ECF2954421020C33C0FDAF5CAA4DD9CD50A4B60 | Rating Details |
| 2022-07-31 23:09:36 -0500 | 47AD3BD4ED0E64C9EA74DB3A322FA6AA5E5F8D84E57A6E405CC624F53C571EC8 | Rating Details |
| 2022-07-31 19:58:16 -0500 | 4855CB592D306D8CFF459F41F8E877A43CF3F6B5990C1E6C04FF1EEF60B6B211 | Rating Details |
| 2022-08-01 18:37:59 -0500 | 49A91801F27BE672336A59B0C4910AD8 | Rating Details |
| 2022-08-01 15:37:24 -0500 | 589100D0FF46B1E4801D84B0876F774D | Rating Details |
| 2022-08-01 10:17:12 -0500 | 5B5E2F78D1FC73D14EFCABA281A8A44D | Rating Details |
| 2022-08-01 01:06:21 -0500 | 5DF07B6C9A656C2725044B45E412CB3B | Rating Details |
| 2022-07-31 18:33:34 -0500 | 6CBAD33E73695603FE2D08B5E3EB696F21AB8F18C50E96494D5E00281D9D52F1 | Rating Details |
| 2022-07-31 18:19:08 -0500 | 75DE5091E62053B99DD7EBEBFF9749047814415565DFD373C77AA987F69444BC | Rating Details |
| 2022-08-01 16:46:37 -0500 | 833B46064EF8D4BFF9E9A354C87A85BE | Rating Details |
| 2022-07-31 18:19:08 -0500 | 84656258148090979F23255CE507BE9C | Rating Details |
| 2022-08-01 07:31:33 -0500 | 87F9A3AD36213601F705EC926F742E9B | Rating Details |
| 2022-07-31 21:25:44 -0500 | 8ADC0E71041E106B2F239AFD602F99C0FC3948F93467A3023CCC6C975DD51726 | Rating Details |
| 2022-07-31 23:09:36 -0500 | 9795BF8962792425EFA8D2F4F92685B4 | Rating Details |
| 2022-07-31 17:50:03 -0500 | A1B70F87989D612C6ACA67B3990A875E | Rating Details |
| 2022-08-01 20:35:11 -0500 | A8CB5D5E5A53FEA286C15D44FBE39BF6 | Rating Details |
| 2022-08-01 07:31:33 -0500 | B1C5C2AFA728FEA2FB000676C4042D8A4B1414189951660003FAB89BECD98269 | Rating Details |
| 2022-07-31 19:58:16 -0500 | B27C8625E0D0F0D41CE8F57DC949FF25 | Rating Details |
| 2022-07-31 23:37:24 -0500 | B3316818B303A24D51A8859B62CD4B81 | Rating Details |
| 2022-07-31 20:45:39 -0500 | B46778D059867FD80E43FB8C516756C5019E0B5E1D8139805880327392DC6BCC | Rating Details |
| 2022-07-31 20:45:39 -0500 | BDDA566A7A93EA403EF2CFCD4B70AA95 | Rating Details |
| 2022-08-01 08:05:25 -0500 | C5C9ED85DB2B8785D22394F449801E65 | Rating Details |
| 2022-07-31 20:06:09 -0500 | C6932488574F7CBE3F1855D6C74B408F3BD254D3CD91A05D2E694BBC284B5C56 | Rating Details |
| 2022-07-31 18:33:34 -0500 | CBF074C97A4AFEF972B6C381CBE53FE2 | Rating Details |
| 2022-07-31 21:25:44 -0500 | D704BACE8F9B7D391375AE0223A4491B | Rating Details |
| 2022-07-31 17:50:03 -0500 | E0169BA2305ACBAA51408AD4EC695D9C5A8C3E5052BB071A062ED41C97E05495 | Rating Details |
| 2022-08-01 08:00:06 -0500 | E30B003A1AD604C7B9788EE78E6AD09D | Rating Details |
| 2022-08-01 18:37:59 -0500 | E99F2166763AB02EE87D5C31F0CFFB4FB5F929A6800C0E63C01F0EE353401676 | Rating Details |
| 2022-07-31 23:37:24 -0500 | EFA3DB0AE9A96B53AF18ACE737520E5C2F00AF166D569CAD1847C8F78A3ADD52 | Rating Details |
| 2022-07-31 18:33:34 -0500 | Rating Details | |
| 2022-08-01 07:31:33 -0500 | Rating Details | |
| 2022-08-01 08:05:25 -0500 | Rating Details | |
| 2022-08-01 08:00:06 -0500 | Rating Details | |
| 2022-08-01 15:37:24 -0500 | Rating Details | |
| 2022-08-01 18:37:59 -0500 | Rating Details | |
| 2022-07-31 20:06:09 -0500 | Rating Details | |
| 2022-07-31 17:50:03 -0500 | Rating Details | |
| 2022-08-01 20:35:11 -0500 | Rating Details | |
| 2022-08-01 10:17:12 -0500 | Rating Details | |
| 2022-07-31 23:37:24 -0500 | Rating Details | |
| 2022-08-01 16:46:37 -0500 | Rating Details | |
| 2022-07-31 21:25:44 -0500 | Rating Details | |
| 2022-07-31 19:58:16 -0500 | Rating Details | |
| 2022-08-01 01:06:21 -0500 | Rating Details | |
| 2022-07-31 20:45:39 -0500 | Rating Details | |
| 2022-07-31 23:09:36 -0500 | Rating Details | |
| 2022-07-31 18:19:08 -0500 | Rating Details |